Following a review of currently available evidence, Consortium members have agreed to promote the following 5 principles in our advocacy work with governments and international agencies.

• Drug Policy Decisions Should be More Informed by the Best Available Evidence.
• Drug Policies Should Shift Focus and Priority from Reducing the Scale of the Drug Market to Reducing its Negative Consequences.
• Efforts to Reduce the Supply of Drugs Should Not Focus on the Punishment of Growers.
• Efforts to Reduce the Demand for Drugs Should Not Focus on The Punishment Of Users.
• The UN System Should Develop a More Co-ordinated and Cohesive Approach to Drug Policy Issues.